AzTrials
AzTrials

Bowel Preparation QualityAIBPNCT06904209

Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, Without Compromising the Quality of Colonoscopy? An International Multi-centre Randomized Controlled Trial.

A study testing AI in people with Bowel Preparation Quality, run by Chinese University of Hong Kong at 1 site in Hong Kong.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to assess the clinical and cost-effectiveness of the AI bowel preparation evaluation system in reducing the consumption volume of the standard high-volume PEG regimen before colonoscopy among the older population. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Bowel Preparation Quality
What is being tested?
AI
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,824 participants
Where
1 siteHong Kong
Study dates
1 Jun 2026to 30 Jun 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • individual aged 65 years or above
  • undergoing colonoscopy for any indication
  • requiring a standard high-volume PEG regimen for bowel preparation
  • having a smartphone themselves or their caregivers (including ward nurses) having one will be recruited.

Who cannot join

  • allergy to PEG,
  • suspected or diagnosed gastrointestinal obstruction or perforation,
  • suspected or diagnosed ileus
  • suspected or diagnosed gastric retention
  • suspected or diagnosed toxic colitis, toxic megacolon,
  • prior gastrointestinal surgery, and
  • unable to provide informed consent.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Hong Kong1 site
  • Centre of Digestive Health

    Hong Kong

Other trials in Hong Kong

About this study

The goal of this study is to assess the clinical and cost-effectiveness of the AI bowel preparation evaluation system in reducing the consumption volume of the standard high-volume PEG regimen before colonoscopy among the older population.

Researchers will compare bowel preparation adequacy and other colonoscopy quality matrices, and patient satisfaction between patients using the AI system and those using Standard Practice.

Read the detailed description

Colonoscopy is the gold standard for screening colorectal cancer (CRC), which is the third most common cancer and the second leading cause of cancer-related mortality worldwide. Polypectomy during screening colonoscopy reduces both the long-term incidence and mortality of CRC because the removal of adenomatous polyps, the precursors of CRC, prevents the development of CRC by interrupting the adenoma-carcinoma sequence. As the older population grows, the demand for colonoscopy is increasing rapidly because of indications for treatment, diagnosis and surveillance, as well as the wide global implementation of organized CRC screening program for individuals ≥50 years.

Bowel preparation plays a crucial role in colonoscopy because it directly affects two important quality indicators that contribute to procedural accuracy: cecal intubation rate (CIR) and adenoma detection rate (ADR). Adequate bowel preparation is essential for complete visualization of the colonic mucosa and the detection of colorectal lesions. In contrast, inadequate bowel preparation (IBP) is associated with a lower CIR, longer procedural time, increased risk of complications, higher adenoma miss rate, and increased healthcare costs owing to the need for earlier repeat colonoscopy. These negative consequences place a significant burden on both patients and the healthcare system. IBP is a common issue worldwide, with rates reported to range from 11% to 28% in the general population undergoing colonoscopy and up to 50% in older individuals.

Enhanced bowel preparation instructions are recommended16. Effective strategies include providing additional instructions, visual aids, cartoons, booklets, videos, phone calls, short message services, smartphone applications and mobile messenger.

Over the past decade, there has been an exponential increase in the computational power, reduced data storage costs, improved algorithmic sophistication, and an increased availability of electronic health data. Artificial intelligence (AI) has been widely adopted in various healthcare settings, particularly for colonoscopy17.

A recent meta-analysis reported that brown liquid rectal effluent is one of the most significant risk factors for IBP, increasing the odds by more than 4.5-fold.18. Some newly developed convolutional neural network (CNN)-based AI models, trained using thousands of rectal effluent images, have been validated in randomized controlled trials (RCTs) as effective tools for guiding bowel preparation before colonoscopy19,20. Unlike enhanced instructions that focus on patient education, these AI models allow patients to predict the adequacy of bowel preparation before colonoscopy by analyzing rectal effluent images.

In one study, the AI model demonstrated comparable performance in predicting bowel preparation adequacy to standard practice (SP) of self-evaluation using written instructions with photographic examples (AI: 90.7% vs SP: 91.5%, p=0.976), while patients in AI group achieved a higher mean Boston Bowel Preparation Scale (BBPS) score (7.32±1.4 vs 7.16±1.46, p=0.044)19. In another study, the AI model achieved a higher bowel preparation adequacy rate (88.54% vs 65.59%, p <0.001) and a higher mean BBPS score (6.74±1.25 vs 5.97±1.81, p <0.001) than those in the SP 20. These AI models were developed as mobile apps or websites accessible via smartphones. In HK, the overall smartphone ownership rate has rapidly increased to 93% recently: 73% among individuals aged ≥65 years versus 99% among those aged 45-64 years21. The social media participation rate was 83% across age groups and 78% among those aged ≥45 years22. The AI bowel preparation evaluation system only requires patients to take and upload photographs of their rectal effluent, with the evaluation results provided immediately on the same page, making it simpler to use than social media. This indicates the feasibility of using a smartphone-based AI bowel preparation evaluation system, even in the older population. Caregivers can assist older individuals with low digital literacy with AI evaluations. For those who live alone, have limited mobility, or have advanced medical conditions, the usual practice is to admit them for inpatient colonoscopy. This means that ward nurses can perform AI evaluations.

Although two studies reported the effectiveness of AI in improving the bowel preparation quality, there are several important gaps in the existing research. First, one study had a relatively small sample size of approximately 500 patients20, and both studies were conducted in a single country, limiting the generalizability of their findings. Second, the baseline ADR in the SP group in both studies did not meet the international quality benchmark of 25%23,24. In one study, the baseline bowel preparation adequacy in the SP group was only 65.6%, and the mean BBPS score was 5.97, both of which were below the recommended standard23,25. Third, the same study allowed for a 1 L remedial dose on top of the split 3 L PEG regimen if the rectal effluent was deemed IBP by the patient's or AI evaluation. As a result, more patients in the AI group consumed a total of 4 L PEG compared to those in the SP group20. It is uncertain that if the increase in bowel preparation adequacy rate in the AI group was due to an increased PEG dosage or AI use. Fourth, although both studies reported that AI could enhance bowel preparation adequacy, they failed to demonstrate its efficacy in enhancing adenoma detection during colonoscopy. Finally, most of the patients recruited in these two studies did not have high-risk factors for IBP as they were generally young, healthy, free of advanced medical conditions, and had undergone elective outpatient colonoscopies19,20.

Although there are different bowel preparation regimens, high-volume PEG is the most commonly used, particularly for the older population, because of its high safety and efficacy in achieving adequate bowel preparation quality16,26,27. Older population is also at a higher risk of developing IBP18. One reason for this is that they tend to dislike and poorly tolerate high-volume PEG regimens with unpleasant taste9,27. Thus, there is a clear need to improve the acceptance and tolerability of high-volume PEG regimens in the older population.

To the best of our knowledge, no studies have explored the feasibility and effectiveness of AI bowel preparation evaluation in reducing the consumption of high-volume PEG while maintaining bowel preparation adequacy among older populations who are at higher risk of IBP18 and require standard high-volume PEG for safety reasons16,26,27. Furthermore, the cost-effectiveness of AI bowel preparation evaluation before colonoscopy has not yet been investigated. Therefore, we aimed to conduct a large-scale, international, multi-centre randomized controlled trial (RCT) to assess the clinical and cost-effectiveness of an AI bowel preparation evaluation system in reducing the consumption volume of the standard high-volume PEG regimen among older population, without compromising the bowel preparation adequacy and other colonoscopy quality matrices.

Being tested
AI
Keywords
PEG, bowel preparation, colonoscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AIDevice

    Each photo will be uploaded and analyzed by AI to predict the adequacy of their bowel preparation with immediate results of "pass" or "not pass," indicating if their bowel preparation is adequate or inadequate. If the result is "pass," patients will stop consuming the remaining PEG solution. If the result is "not pass," patients will be advised to gently rub their lower abdomen in a clockwise direction or walk around and continue consuming the remaining PEG until the AI evaluation gives a "pass" result or until the full dose of 3 L PEG have been consumed. If the patient's rectal effluent deems IBP after consumption of the full dose of 3 L of PEG, an additional 1 L or more of PEG will be administered as a remedial dose at the discretion of the physician-in-charge.

Study groups in NCT06904209
Study groupRoleWhat they receive
Standard practice group (SP group)No interventionAll patients undergoing outpatient colonoscopy will follow the standard bowel preparation regimen, which includes low residue diet three days prior colonoscopy, and high-volume (3 L) PEG (Klean-Prep, Helsinn Birex Pharmaceuticals, Ireland) in split-dose using a tailored measuring cup (Figure 2). Patients will be asked to consume 1 L in the evening before colonoscopy and 2 L in the morning of colonoscopy. To achieve the best bowel-cleansing effect, patients will be instructed to consume 2 L of PEG 3-6 hours before their colonoscopy9,27. Patients will be instructed to consume the purgative at a rate of 250 ml every 15 minutes14 and document the amount consumed.
AI bowel preparation (AI group)ExperimentalPatients who were randomized to the AI bowel preparation evaluation group will follow the same standard practice with the addition of an online AI bowel preparation evaluation system via a QR code. They will be instructed to take photos of their rectal effluent each time they use the toilet during the consumption of the split dose of 2 L PEG on the day of colonoscopy.
Receives: Device: AI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Volume of PEG consumed

    The primary outcome of this study is the volume of PEG consumed before colonoscopy between the AI and SP groups.

    Measured: Baseline (before colonoscopy procedure)

Secondary outcomes (8)
  1. BBPS score

    BBPS during procedure

    Measured: during colonoscopy

  2. Bowel preparation adequacy rate

    How adequate the bowel preparation rate

    Measured: during colonoscopy

  3. Caecal intubation rate

    Rather it was successful or not caecum is reached during colonscopy

    Measured: during colonoscopy

  4. Adenoma detection rate

    The chance of discovering adenoma

    Measured: during colonoscopy

  5. Mean adenoma per colonoscopy

    average number of adenoma found

    Measured: during colonoscopy

  6. withdrawal time

    time it takes to withdraw

    Measured: during colonoscopy

  7. bowel preparation tolerability questionnaire

    rather person can handle the bowel preparation

    Measured: Baseline (before colonoscopy procedure)

  8. satisfaction between AI and SP group questionnaire

    rather patient enjoy using AI or not

    Measured: Baseline (before colonoscopy procedure)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Apr 2025
  2. Study start1 Jun 2026 (estimated)
  3. Primary completion31 Jan 2028 (estimated)
  4. Study completion30 Jun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
1,824 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06904209
Sponsor's protocol ID
2024.590
Acronym
AIBP
Status last verified
Mar 2025
First submitted
25 Mar 2025
Last updated
1 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing AI in people with Bowel Preparation Quality, run by Chinese University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 1 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Felix Sia (852-26370428, felixsia@cuhk.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Volume of PEG consumed (time frame: Baseline (before colonoscopy procedure)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in